In this study, we found that miR-101 expression was significantly down-regulated in ER/PR−, HER2−,ER/PR+, HER2+,ER/PR+, HER2− and ER/PR−, HER2+ breast cancer tissues compared with that in adjacent normal breast tissues. Here, ERBB2 is linked to breast carcinoma.